Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Companies
  3. therapeutic potential
Show results for
Products
Services
Software
Applications

Companies

News
Articles
Books
Downloads
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Africa
  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Business Types

  • Manufacturer
  • Technology
  • Service provider
  • Software vendor
Industries served

  • Medical / Health Care
  • Chemical & Pharmaceuticals
Employees

  • Over 1000

Therapeutic Potential Suppliers & Manufacturers

48 companies found

Advancells

Advancells

based inNoida, INDIA
Advancells is a research-oriented company, focussed on offering authentic, high-quality primary cells including stem cells for research studies, stem cell therapy, preclinical analysis, and even as in vitro tools for clinical research. We wish to be ...
CONTACT SUPPLIER

Creative Peptides

Creative Peptides

based inNew York, NEW YORK (USA)
Creative Peptides is specialized in the process development and the manufacturing of bioactive peptides. We are dedicated to offering custom peptide synthesis, process development, GMP manufacturing as well as catalog products for customers in ...
Creative Peptides - Peptide-drug Bioconjugations

Creative Peptides - Peptide-drug Bioconjugations

The field of bioconjugation has had a considerable impact on academic research, clinical diagnostics and the production of therapeutics. Peptides are an important type of molecules for derivatization by bioconjugation. ...
CONTACT SUPPLIER

AC BioScience SA

AC BioScience SA

based inEpalinges, SWITZERLAND
AC BioScience Ltd., a clinical-stage biotech company and a developer of immune modulating and angiogenic cancer therapies. AC BioScience LTD. is a Swiss biotech company, pioneering the development of novel therapies in immuno-oncology and tumor ...
CONTACT SUPPLIER

Immatics N.V.

Immatics N.V.

based inTuebingen, GERMANY
Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. This deep know-how is the foundation ...
Immatics TCER - Bispecific T cell Engaging Receptors

Immatics TCER - Bispecific T cell Engaging Receptors

Bispecific T cell engaging receptors (TCER®) are off-the-shelf biologics that leverage the body’s immune system by redirecting and activating T cells towards cancer cells expressing specific tumor targets. The design of these novel ...
CONTACT SUPPLIER

Champions Oncology, Inc.

Champions Oncology, Inc.

based inHackensack, NEW JERSEY (USA)
At Champions Oncology, we are passionate about aiding the pharmaceutical industry in developing the innovative treatments of today and the cures for tomorrow. We provide end-to-end research and development solutions throughout the drug development ...
CONTACT SUPPLIER

Exeliom Biosciences

Exeliom Biosciences

based inDijon, FRANCE
At Exeliom Biosciences, we develop novel therapeutic approaches to unleash the therapeutic potential of key players in the Microbiome - Host interactions to fight immune-mediated diseases, starting with inflammatory bowel diseases. There is a time ...
Faecalibacterium prausnitzii (F. prau)

Faecalibacterium prausnitzii (F. prau)

Faecalibacterium prausnitzii (F. prau), a key bacterium to treat Crohn’s Disease Meet Faecalibacterium prausnitzii (F. prau) WHAT IS F. prau? F. prau, is a dominant member of the healthy gut microbiome. It accounts for 5% to 15% of the total ...
CONTACT SUPPLIER

Berkshire Biomedical

Berkshire Biomedical

based inDallas, TEXAS (USA)
Berkshire Biomedical is developing a Revolutionary Secure Medication Delivery for the Intended User combined with a Physician-Enabled Management System. Secure Medication Delivery with Remote Monitoring and Compliance Support is the Most Efficient ...
CONTACT SUPPLIER

Kiadis Pharma NV

Kiadis Pharma NV

based inAmsterdam, NETHERLANDS
Founded in 1997, Kiadis Pharma is a fully integrated biopharmaceutical company committed to developing innovative, personalized, next-generation cell-based immunotherapies for patients with life threatening diseases. With headquarters in Amsterdam, ...
IntelliSelect - Antibody Repertoire Technology

IntelliSelect - Antibody Repertoire Technology

We believe our IntelliSelect® Technology platforms reduce the risk of missing novel solutions and increase the quality and differentiation of antibodies, to identify product candidates with the most desirable drug-like ...
CONTACT SUPPLIER

Futura Medical

Futura Medical

based inGuildford, UNITED KINGDOM
Futura Medical is a pharmaceutical company developing a portfolio of innovative products based on our proprietary, transdermal DermaSys technology. Futura Medical is an innovative R&D company with a pipeline of products in late stage development. ...
Futura - Model CBD100 - Topical Cannabidiol Formulation

Futura - Model CBD100 - Topical Cannabidiol Formulation

Joint venture collaboration. Early development stage completed. IP application filed. Advisers retained to explore commercial ...
CONTACT SUPPLIER

Reaction Biology Corp.

Reaction Biology Corp.

based inMalvern, PENNSYLVANIA (USA)
Since our founding in 2001, we have had one singular obsession: We strive to give our clients a personalized and collaborative research experience. We are here to help you find the answers you need to develop the best possible drug candidate for ...
Reaction Biology - Model ASH1L (His) - Methyltransferase Assay

Reaction Biology - Model ASH1L (His) - Methyltransferase Assay

ASH1L is a large , multi-domain protein associated with actively transcribed regions of chromatin, ASH1L is the human homolog of Drosophila Ash1, a Trithorax group protein. Like its counterpart in Drosophila, ASH1L contains a SET histone ...
CONTACT SUPPLIER

Galapagos NV

Galapagos NV

based inMechelen, BELGIUM
Galapagos discovers, develops and commercializes small molecule medicines with novel modes of action. Our pipeline comprises discovery through to Phase 3 programs in inflammation, fibrosis, and other indications. Our first medicine is approved and ...
Galapagos - SIK Program

Galapagos - SIK Program

The SIK program is a strategic effort to develop assets inhibiting salt-inducible kinases (SIK) as a novel target class in inflammation which we discovered with our proprietary target discovery platform. These molecules inhibit the different members ...
CONTACT SUPPLIER

eNUVIO inc.

eNUVIO inc.

based inMontreal, QUEBEC (CANADA)
eNUVIO three founders first met as graduate students in 2010, working together on an interdisciplinary collaboration between two university science labs in Montreal. At that time, it was obvious that they shared a strong interest for research tool ...
CONTACT SUPPLIER

cellvie Inc.

cellvie Inc.

based inHouston, TEXAS (USA)
cellvie is the leader in Therapeutic Mitochondria Transplantation (TMT). The team is seeking to bring about a novel treatment modality, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell. Therapeutic Mitochondria ...
CONTACT SUPPLIER

MtoZ Biolabs

MtoZ Biolabs

based in, MASSACHUSETTS (USA)
MtoZ Biolabs is an integrate contract research organization (CRO) providing advanced proteomics, metabolomics, bioinformatics, and biopharmaceutical analysis services to researchers in biochemistry, biotechnology, and biopharmaceutical fields. The ...
MtoZ Biolabs - PROTAC Drug Off-Target Protein Assessment Service

MtoZ Biolabs - PROTAC Drug Off-Target Protein Assessment Service

Proteolysis targeting chimera (PROTAC) drugs offer a novel approach to disease treatment by leveraging the body's innate protein degradation pathways. In contrast to traditional small-molecule inhibitors, PROTAC drugs promote the degradation of ...
CONTACT SUPPLIER

ENB Therapeutics

ENB Therapeutics

based inNew York, NEW YORK (USA)
ENB is developing platform oncology molecules to unlock the full therapeutic potential of immune-based cancer therapies. We are developing small molecules that turn off a common “switch” that activates critical pro-cancer components of the TME: the ...
CONTACT SUPPLIER

Galera Therapeutics, Inc.

Galera Therapeutics, Inc.

based inMalvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
CONTACT SUPPLIER

BioXcel Therapeutics, Inc.

BioXcel Therapeutics, Inc.

based inNew Haven, CONNECTICUT (USA)
BioXcel Therapeutics, Inc. is a clinical-stage biopharmaceutical company utilizing artificial intelligence, or AI, approaches to develop transformative medicines in neuroscience and immuno-oncology. We are focused on utilizing cutting-edge ...
CONTACT SUPPLIER

Sibylla Biotech S.p.A.

Sibylla Biotech S.p.A.

based inVerona, ITALY
At Sibylla Biotech, we face the complexity of drug discovery with the power of an innovative approach for meeting unmet medical needs. Born out of a scientific challenge, the PPI-FIT protocol (Pharmacological Protein Inactivation by Folding ...
Sibylla - Early Stage Drug Discovery Technology

Sibylla - Early Stage Drug Discovery Technology

In Silico: Identifying small molecules able to revolutionize drug discovery. The PPI-FIT technology allows the exploration of unique pharmacological targets represented by protein folding intermediates. This places Sibylla Biotech in the exclusive ...
CONTACT SUPPLIER

Juvena Therapeutics, inc.

Juvena Therapeutics, inc.

based inRedwood City, CALIFORNIA (USA)
Juvena Therapeutics is a biotech company accelerating the development of regenerative therapeutics by unlocking the therapeutic potential of secreted proteins. Secreted proteins are a class of biologics with proven therapeutic potential that has ...
Juvena - Decoding Secreted Proteins for Better Human Health

Juvena - Decoding Secreted Proteins for Better Human Health

Secreted proteins are a proven class of biologics with tremendous therapeutic potential, as they regulate tissue repair and regeneration, organ development, and immune response to disease. The characteristics of ...
CONTACT SUPPLIER

Impel Pharmaceuticals Inc.

Impel Pharmaceuticals Inc.

based inSeattle, WASHINGTON (USA)
Impel Pharmaceuticals Inc. is a commercial stage pharmaceutical company focused on developing and providing transformative therapies that unlock the full potential of therapeutic molecules for people suffering from diseases with high unmet medical ...
Impel - Pharmaceuticals Proprietary Precision Olfactory Delivery (POD) Technology

Impel - Pharmaceuticals Proprietary Precision Olfactory Delivery (POD) Technology

Impel Pharmaceuticals has developed a proprietary drug delivery technology system that targets the vascular-rich upper nasal space,1 with multiple clinical trials suggesting rapid absorption and consistent drug bioavailability with ease of use in ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT